LensCrafters 2015 Annual Report Download - page 155

Notes to the consolidated financial statement as of December 31, 2015 Page 61 di 68
A summary of related party transactions as of December 31, 2015 and 2014 is provided below.
(in thousands of Euro)
As of December 31, 2015 Consolidated Statement
of Income
Consolidated Statement
of Financial Position
Related parties Revenues Costs Assets Liabilities
Brooks Brothers Group, Inc. 416 768 29 336
Eyebiz Laboratories Pty Limited 5,563 53,104 10,682 16,358
Salmoiraghi & Viganò 16,848
1
56,361 517
Others 2,457
8,947 10,384 552
Total 25,285
62,820 77,456 17,763
(in thousands of Euro)
As of December 31, 2015 Consolidated Statement
of Income
Consolidated Statement
of Financial Position
Related parties Revenues Costs Assets Liabilities
Brooks Brothers Group, Inc. 452 1,108 202 292
Eyebiz Laboratories Pty Limited 5,642 54,834 10,233 17,144
Salmoiraghi & Viganò 13,753 11 51,076 183
Others 2,214
23,845 2,190 3,318
Total 22,061
79,798 63,701 20,937
Total remuneration due to key managers amounted to approximately Euro 50.8 million and Euro 53.1 million in 2015 and
2014, respectively.
In 2015 and in 2014, transactions with related parties resulted in a cash outflow of approximately Euro 54.6 million and Euro
48.2 million.
30. EARNINGS PER SHARE
Basic and diluted earnings per share were calculated as the ratio of net income attributable to the stockholders of the Company
for 2015 and 2014 amounting to Euro 804.1 million and Euro 642.6 million, respectively, to the number of outstanding
shares—basic and dilutive of the Company.
Basic earnings per share in 2015 were equal to Euro 1.68 compared to Euro 1.35 in 2014. Diluted earnings per share in 2015
were equal to Euro 1.67 compared to Euro 1.34 in 2014.
The table reported below provides the reconciliation between the average weighted number of shares utilized to calculate basic
and diluted earnings per share:
2015
2014
Weighted average shares outstanding—basic 479,553,693 475,947,763
Effect of dilutive stock options 2,519,669 3,299,427
Weighted average shares outstanding—dilutive 482,073,361 479,247,190
Options not included in calculation of dilutive shares as the average value was greater than the average
price during the respective period or performance measures related to the awards have not yet
been
met
2,015,627 1,641,383